Inflammation & Oxidative Stress

Inflammation is part of the body’s normal defense system.

The ocular surface is constantly exposed to the outside world. It encounters air, microorganisms, allergens, particles, changes in humidity and temperature, and many other potential stresses. The immune system therefore needs to monitor and protect this surface.

When cells detect damage, infection or other forms of stress, they can release signaling molecules that activate an immune response. Blood vessels, immune cells and surrounding tissues may then participate in that response.

This is not automatically harmful. Inflammation is fundamentally a protective biological process. The problem arises when inflammatory activity becomes excessive, persistent or poorly regulated. Instead of simply helping the tissue recover, it can begin to contribute to further dysfunction and damage.

There are several possible entry points.

Imagine that the tear film repeatedly becomes unstable and breaks up too early. Areas of the ocular surface may then experience increased evaporation and localized hyperosmotic stress. The epithelial cells covering the eye can detect this abnormal environment. In response, intracellular signaling pathways can become activated and the cells can release inflammatory mediators. These include molecules such as cytokines, chemokines and matrix metalloproteinases.

Those signals can influence neighboring cells and recruit or activate immune cells. So a problem that initially began with the tear film can begin to involve the immune system:

tear-film instability→cellular stress→inflammatory signaling

But the process does not necessarily stop there.

Once inflammatory pathways become activated, they can influence several components of the ocular-surface system. Inflammatory mediators can contribute to epithelial-cell damage and impaired barrier function. They can affect goblet cells and mucin expression. They can interact with sensory nerves. Inflammatory processes may also affect lacrimal and meibomian gland function in some forms of dry eye.

These changes can make it more difficult for the tear film and ocular surface to return to normal homeostasis. This creates another possible feedback loop:

tear-film or surface stress→inflammation→further surface dysfunction→greater tear-film instability

This is part of what is often called the vicious circle of dry eye.

Inflammation is not one single reaction. The immune system has two broadly interacting components: innate immunity and adaptive immunity.

Innate immunity provides a rapid response to tissue stress, damage and potential threats. The epithelial cells of the ocular surface themselves participate in this system. They are not passive victims of inflammation — they can detect stress and produce signals that initiate or amplify an immune response.

Adaptive immunity involves more specialized immune cells, including T cells, which can become involved when inflammatory responses persist.

These systems communicate with one another. In dry eye, experimental and clinical research has shown involvement of both innate and adaptive immune pathways. For a patient, however, the most important idea is simpler: the ocular surface is an active immune environment, and prolonged stress can change how that environment behaves.

Every cell uses oxygen as part of normal metabolism. During these processes, cells naturally produce chemically reactive molecules, including reactive oxygen species, often abbreviated as ROS.

ROS are not automatically harmful. At controlled levels, they participate in normal cellular signaling. Cells also have antioxidant systems that help keep these reactive molecules under control.

Oxidative stress occurs when the balance shifts — when the production of reactive molecules exceeds the ability of antioxidant systems to neutralize or manage them effectively. When that happens, proteins, lipids, DNA and other cellular structures can become damaged.

The ocular surface is particularly exposed to environmental and metabolic stress. Its cells encounter oxygen, light, environmental pollutants, inflammation and continuous mechanical interaction with the eyelids.

Under stressful conditions, production of reactive oxygen species can increase. If antioxidant defenses are unable to compensate adequately, oxidative stress can develop. This can interfere with normal epithelial-cell function and contribute to cellular injury.

Oxidative stress has been identified in experimental and clinical studies of dry eye and has been investigated in several parts of the ocular-surface system, including the cornea, conjunctiva, lacrimal glands and meibomian glands.

But it is important not to turn this into another oversimplification. Dry eye is not simply an “oxidative stress disease.” Oxidative stress is one biological mechanism that may participate in the larger network of abnormalities involved in dry eye.

Inflammation and oxidative stress are different processes, but they can interact closely. Inflammatory activity can increase the production of reactive oxygen species. At the same time, oxidative stress can activate cellular signaling pathways that promote inflammatory responses.

This creates the possibility of another feedback loop:

cellular stress→oxidative stress→inflammatory signaling→additional cellular stress

In some situations, these processes may therefore reinforce one another. But their relative importance is unlikely to be identical in every person with dry eye.

This is one of the most important ideas in this article.

Suppose a person begins with a problem involving the meibomian glands. Abnormal meibum delivery may contribute to tear-film instability. That instability may create greater ocular-surface stress. Surface cells can then generate inflammatory signals. Inflammation can subsequently contribute to additional surface dysfunction. In this situation, inflammation may have developed downstream of the original problem.

But there are also conditions in which inflammatory or immune processes may be much closer to the beginning of the disease pathway.

So asking “Is inflammation the cause of my dry eye?” does not always have a simple yes-or-no answer. A better question may be: “What role is inflammation playing in my particular dry-eye system?”

Not necessarily in the same way, at the same level or at every stage of disease.

The TFOS definition recognizes ocular-surface inflammation as an important etiological factor in dry eye, but that does not mean clinically obvious inflammation must be demonstrated in every patient.

Dry eye is a multifactorial disease. Different people can have different combinations of tear-film instability, hyperosmolarity, inflammation, ocular-surface damage and neurosensory abnormalities. And those relationships can change over time.

This is why the presence of dry-eye symptoms does not automatically tell us how much inflammation is present — or whether inflammation is the dominant problem.

Inflammation does not always produce dramatic redness or swelling. Biological inflammatory activity can exist at a level that is not obvious simply by looking at the eye. This is sometimes described as subclinical inflammation. Cells may be producing inflammatory mediators and immune pathways may be activated even when the eye does not look severely inflamed.

Conversely, visible redness does not automatically prove that dry-eye inflammation is the cause. Many different ocular conditions can produce redness.

So appearance alone cannot tell us the entire inflammatory state of the ocular surface.

Yes, but the relationship is complex.

Inflammatory mediators can interact with sensory nerve endings and alter how those nerves respond to stimuli. This can contribute to burning, irritation, pain or other abnormal sensations.

But symptoms are not produced by inflammation alone. Tear-film instability, hyperosmolarity, mechanical friction, epithelial damage and neurosensory abnormalities can all influence what a person feels.

This is another reason why symptom severity and visible signs do not always match perfectly. Two people with apparently similar ocular-surface findings may experience very different levels of discomfort.

Because dry eye is a system.

A person may have inadequate aqueous tears. Another may have abnormal meibum delivery. Another may blink incompletely. Another may have an ocular-surface disorder. Another may have altered sensory processing. And many people have several abnormalities at the same time.

Inflammation can interact with all of these pathways, but calling every dry-eye problem simply “inflammation” can hide the mechanism that started or continues to drive the problem. This matters because understanding what is actually dysfunctional is more informative than assigning one universal explanation to everyone with dry eye.

There are many possible reasons. They can occur downstream of tear-film instability, hyperosmolarity and ocular-surface stress, but they can also be associated with immune disease, environmental stress, infection, eyelid disease, medications, surgery and many other conditions. Oxidative stress can likewise be influenced by multiple biological and environmental factors.

Those are questions about why these processes became important in a particular person. For now, the important point is that both inflammation and oxidative stress can become part of the biological environment that prevents the tear film and ocular surface from maintaining normal homeostasis.